Arcellx (ACLX) Liabilities and Shareholders Equity (2021 - 2025)

Arcellx (ACLX) recorded quarterly Liabilities and Shareholders Equity of $604.0 million in Q4 2025, down 7.92% quarter-over-quarter from $655.9 million in Q3 2025, and down 15.09% on a YoY basis from $711.3 million in Q4 2024.

Arcellx (ACLX) Liabilities and Shareholders Equity (2021 - 2025) Analysis & Trends

Arcellx's Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $604.0 million for Q4 2025.

  • In Q4 2025, Liabilities and Shareholders Equity fell 15.09% year-over-year to $604.0 million; the TTM figure through Dec 2025 stood at $2.5 billion (down 15.49% YoY), while the FY2025 annual figure was $604.0 million, down 15.09% from the prior year.
  • Liabilities and Shareholders Equity was $604.0 million for Q4 2025 at Arcellx, down from $655.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $825.1 million in Q4 2023 to a low of $128.8 million in Q4 2021.
  • Historically, Liabilities and Shareholders Equity has averaged $565.0 million across 5 years, with a median of $622.9 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity surged 162.93% in 2023, then slipped 16.88% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $128.8 million in 2021, then soared by 143.68% to $313.8 million in 2022, then soared by 162.93% to $825.1 million in 2023, then fell by 13.79% to $711.3 million in 2024, then slipped by 15.09% to $604.0 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $604.0 million (Q4 2025), $655.9 million (Q3 2025), and $619.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 603.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 603.99 Mn
Sep 30, 2025 655.92 Mn
Jun 30, 2025 619.09 Mn
Mar 31, 2025 648.08 Mn
Dec 31, 2024 711.33 Mn
Sep 30, 2024 764.91 Mn
Jun 30, 2024 734.31 Mn
Mar 31, 2024 779.70 Mn
Dec 31, 2023 825.13 Mn
Sep 30, 2023 614.22 Mn
Jun 30, 2023 623.53 Mn
Mar 31, 2023 622.94 Mn
Dec 31, 2022 313.82 Mn
Sep 30, 2022 337.33 Mn
Jun 30, 2022 374.66 Mn
Mar 31, 2022 246.98 Mn
Dec 31, 2021 128.78 Mn